Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display

2171 - Radio guided sentinel lymph node detection and mapping in invasive urinary bladder cancer - a prospective clinical study


09 Oct 2016


Poster display


Firas Aljabery


Annals of Oncology (2016) 27 (6): 266-295. 10.1093/annonc/mdw373


F. Aljabery1, I. Shabo2, H. Olsson3, O. Gimm4, S. Jahnson5

Author affiliations

  • 1 Department Of Urology, Institution of Clinical and Experimental Medicine, 58185 - Linköping/SE
  • 2 Unit Of Endocrine And Sarcoma Surgery, Institutionen för molekylär medicin och kirurgi (MMK), K1, Stockholm/SE
  • 3 Department Of Pathology, Institution of Clinical and Experimental Medicine, 58185 - Linköping/SE
  • 4 Department Of Surgery, Institution of Clinical and Experimental Medicine, Linköping/SE
  • 5 Department Of Urology, Institution of Clinical and Experimental Medicine, Linköping/SE


Abstract 2171


Muscle invasive urinary bladder cancer (UBC) is associated with pathologic lymph node (LN). Lymphadenectomy is a routine surgical method to treat UBC, but it cause great surgical trauma and morbidity. Sentinel node biopsy technique (SNB) is a successful surgical procedure used in evaluating LN metastasis in treatment of several tumor types. In this study, we investigated systematically the reliability of SNB for detection of pathological LN during cystectomy, the significance of tumor localization in the bladder to predict the site of LN metastasis, as well as the prognostic significance of LN metastasis density (LNMD) on survival.


The study included 103 patients with UBC, stages T1-T4, who were treated with cystectomy and pelvic lymph node dissection during 2005-2011 at the Department of Urology, Linköping University Hospital. Intravesical injections of the radioactive tracer Nanocoll 70 MBq and blue dye were injected in the bladder wall around the primary tumor prior to surgery. SNB was detected ex vivo during the operation with a hand-hold Geiger probe (Neoprobe Gamma Detection System). All LNs were formalin-fixed, sectioned three times and stained with haematoxylin-eosin. All slides were evaluated by an experienced uro-pathologist.


The mean age of the patients was 69 years and 80 (77%) patients were male. Pathological staging was T1 N = 12 (12%), T2 N = 20 (19 %), T3 N = 48 (47%) and T4 N = 23 (22%). There were 3253 nodes examined, mean 31 LN/patient, range 7-68. LN metastases occurred in 41 (40 %) patients. Sentinel nodes were detected in 83 (80%) patients. The sensitivity and specificity of detecting metastatic disease by SNB varied between pelvic LN stations with an average value of 67% and 90% respectively. LNMD ≥8% were significantly related to shorter survival (p 


SNB is not a reliable technique for per-operative localization of LN metastases during cystectomy for UBC. LNMD and LVI have a significant prognostic value in UBC and may be a useful variables in the clinical context and in UBC research. Tumor localization in the bladder predicts location of positive LN in pelvis.

Clinical trial identification

Legal entity responsible for the study

Department of urology, University Hospital in Linköping, Sweden.


FoU and ALF research grants from the County Council of Östergötland, Linköping, Sweden.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings